Relationship between circulating vascular cell adhesion molecule-1 and microvascular complications in Type 2 diabetes mellitus

Diabetic Medicine

Volumn 15, Issue 8, 1998, Pages 661-667

  Koga, M ^a   Otsuki, M ^b   Kubo, M ^a   Hashimoto, J ^a   Kasayama, S ^b  

^a Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Diabetes mellitus; Nephropathy; Neuropathy; Retinopathy; Vascular cell adhesion molecule 1

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN A1C; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; ENDOTHELIUM INJURY; FEMALE; GLOMERULOPATHY; HUMAN; JAPAN; KIDNEY TUBULE DAMAGE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; VASCULAR ENDOTHELIUM;

ANALYSIS OF VARIANCE; ARTERIAL OCCLUSIVE DISEASES; BIOLOGICAL MARKERS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031821245     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199808)15:8<661::AID-DIA645>3.0.CO;2-G     Document Type: Article

References (32)

1. Bevilacqua MP, Nelson RM, Mannori G, Cecconi O. Endothelial-leukocyte adhesion molecules in human disease. Ann Rev Med 1994; 45: 361-378.
2. Springer TA. Adhesion receptors for the immune system Nature 1990; 346: 425-434.
3. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, Lobb R. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989; 59: 1203-1211.
4. Elices MJ, Osborn L, Takada, Y, Crouse C, Luhowskyj S, Hemler ME, Lobb R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990; 60: 577-584.
5. Briscoe D, Shoen FJ, Rice GE, Bevilacqua MP, Ganz P, Pober JS. Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts. Transplantation 1991; 51: 537-539.
6. Koch AE, Burrows JC, Haines GK, Carlos TM, Harlan JM, Leibovich J. Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab Invest 1991; 64: 313-320.
7. Rice GE, Bevilacqua MP. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 1989; 246: 1303-1306.
8. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991; 251: 788-791.
9. O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993; 92: 945-951.
10. Pigott R, Dillon LP, Hemingway IH, Gearing AJH. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992; 187: 584-589.
11. Gearing AJH, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann NY Acad Sci 1992; 667: 324-331.
12. Wenisch C, Myskiw D, Parschalk B, Hartmann T, Dam K, Graninger W. Soluble endothelium-associated adhesion molecules in patients with Graves′ disease. Clin Exp Immunol 1994; 98: 240-244.
13. Wellicome SM, Kapahi P, Mason JC, Lebranchu Y, Yarword H, Haskard DO. Detection of a circulating form of vascular cell adhesion molecule-1 : raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol 1993; 92: 412-418.
14. Banks RE, Gearing AJH, Hemingway IK, Norfolk DR, Perren TJ, Selby PJ. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer 1993; 68: 122-124.
15. Rabb H, Calderon E, Bittle PA, Ramirez G. Alterations in soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in hemodialysis patients. Am J Kidney Dis 1996; 27: 239-243.
16. Steiner M, Reinhard KM, Krammer B, Ernst B, Blann AD. Increased levels of soluble adhesion molecules in types 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thromb Haemost 1994; 72: 979-984.
17. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, et al. Advanced glycation endproclucts interacting with their endothelial receptor induce expression of VCAM-1 in human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 1995; 96: 1395-1403.
18. Fasching P, Veitl M, Rohac M, Streli C, Schneider B, Waldhäusl W, Wagner OF. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 4313-4317.
19. Schmidt AM, Crandall J, Hori O, Cao R, Lakatta E. Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria. A marker of vascular dysfunction and progressive vascular disease. Br J Haematol 1996; 92: 747-750.
20. Cominacini L, Pasini AF, Garbin U, Davoli A, De Santis A, Campagnola M, et al. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM. Diabetologia 1995; 38: 1122-1124.
21. World Health Organization Study Group. Diabetes Mellitus. WHO Technical Report Series 727. Geneva: WHO, 1985: 1-113.
22. Aiello LM, Cavallerano JD. Ocular complications of diabetes mellitus. In: Kahn CR, Weir GC, eds. Joslin's Diabetes Mellitus, 13th edn. Malven: Lea & Febiger, 1994: 771-793.
23. Krolewski AS, Lori MB, Krolewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995; 332: 1251-1255.
24. Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic retinopathy and albuminuria: a preliminary multicenter trial. N Engl J Med 1984; 311: 365-372.
25. Watts GF, Bennett JE, Rowe DJ, Morris RW, Gatling W, Shaw KM, Polak A. Assessment of immunochemical methods for determining low concentrations of albumin in urine. Clin Chem 1986; 32: 1544-1548.
26. Rice GE, Munro JM, Corless C, Bevilacqua MP. Vascular and nonvascular expression of INCAM-110. Am J Pathol 1991; 138: 385-393.
27. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Ann Rev Immunol 1993; 11: 767-804.
28. Otsuki M, Hashimoto K, Morimoto Y, Kishimoto T, Kasayama S. Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients. Diabetes 1997; 46: 2096-2101.
29. Seron D, Cameron, JS, Haskard DO. Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant 1991; 6: 917-922.
30. Jensen T, Bjerre-Knudson J, Feldt-Rasmussen B, Deckert T. Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1989; i: 461-463.
31. Baumgartner-Parzer SM, Wagner L, Gessl A, Waldhäusl W. Modulation by high glucose of adhesion molecule expression in cultured endothelial cells. Diabetologia 1995; 38: 1367-1370.
32. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995; 376: 517-519.